(Q73128410)
Statements
All trans-retinoic acid decreases early mortality in patients with promyelocytic leukemia and can be given entirely on an outpatient basis (English)
G J Ruiz-Argüelles
E Lobato-Mendizábal
J L Delgado-Lamas
D Gómez-Almaguer